We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice

    Tau oligomers play critical roles in tau pathology and are responsible for neuronal cell death and transmitting the disease in the brain....

    Sungsu Lim, Seulgi Shin, ... Yun Kyung Kim in Experimental & Molecular Medicine
    Article Open access 13 March 2023
  2. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice

    Accumulation of neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau is a histopathological hallmark of Alzheimer’s disease (AD) and...

    Shuai Zhao, Ziqi Fan, ... Baorong Zhang in Neurotherapeutics
    Article Open access 23 November 2022
  3. TDP-43 pathology is associated with increased tau burdens and seeding

    Background

    Most Alzheimer’s Disease (AD) cases also exhibit limbic predominant age-related TDP-43 encephalopathy neuropathological changes (LATE-NC),...

    Sandra O. Tomé, Grigoria Tsaka, ... Dietmar Rudolf Thal in Molecular Neurodegeneration
    Article Open access 30 September 2023
  4. LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression

    Background

    Mutations in leucine-rich repeat kinase 2 ( LRRK2 ) are the most common cause of familial Parkinson’s disease (PD). These mutations elevate...

    Noah Lubben, Julia K. Brynildsen, ... Michael X. Henderson in Translational Neurodegeneration
    Article Open access 04 March 2024
  5. Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice

    The cholinesterase inhibitor donepezil is used to improve Aβ pathology and cognitive function in patients with Alzheimer’s disease (AD). However, the...

    Hee-Jeong Choi, Jin-Hee Park, ... Hyang-Sook Hoe in Molecular Brain
    Article Open access 18 July 2022
  6. Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targeting

    Tauopathies are neurodegenerative diseases that typically require postmortem examination for a definitive diagnosis. Detecting neurotoxic tau...

    Liara Rizzi, Lea T. Grinberg in Acta Neuropathologica Communications
    Article Open access 28 February 2024
  7. Accurate digital quantification of tau pathology in progressive supranuclear palsy

    The development of novel treatments for Progressive Supranuclear Palsy (PSP) is hindered by a knowledge gap of the impact of neurodegenerative...

    Tanrada Pansuwan, Annelies Quaegebeur, ... Timothy Rittman in Acta Neuropathologica Communications
    Article Open access 09 November 2023
  8. Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology

    Tau deposits in astrocytes are frequently found in Alzheimer’s disease (AD) and other tauopathies. Since astrocytes do not express tau, the...

    Tobias Mothes, Benjamin Portal, ... Anna Erlandsson in Acta Neuropathologica Communications
    Article Open access 17 June 2023
  9. The Spectrum of Tau Pathology in Human Prion Disease

    Intracellular deposition of hyperphosphorylated tau characterizes tauopathies: there is a spectrum from neuron-predominant through mixed neuronal and...
    Gabor G. Kovacs, Herbert Budka in Prions and Diseases
    Chapter 2023
  10. ANU-ADRI scores, tau pathology, and cognition in non-demented adults: the CABLE study

    Background

    It has been reported that the risk of Alzheimer’s disease (AD) could be predicted by the Australian National University Alzheimer Disease...

    Shan Yin, Pei-Yang Gao, ... Lan Tan in Alzheimer's Research & Therapy
    Article Open access 26 March 2024
  11. Phosphorylation of Truncated Tau Promotes Abnormal Native Tau Pathology and Neurodegeneration

    Abnormal posttranslational modifications of tau play important roles in mediating neurodegeneration in tauopathies including Alzheimer’s disease....

    Longfei Li, Yanli Jiang, ... Xiaochuan Wang in Molecular Neurobiology
    Article 28 July 2022
  12. Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

    An unresolved question for the understanding of Alzheimer’s disease (AD) pathophysiology is why a significant percentage of amyloid-β (Aβ)-positive...

    Bruna Bellaver, Guilherme Povala, ... Tharick A. Pascoal in Nature Medicine
    Article Open access 29 May 2023
  13. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation

    Apolipoprotein E4 ( APOE4 ) is the strongest genetic risk factor for late-onset Alzheimer’s disease (LOAD), leading to earlier age of clinical onset...

    Maxine R. Nelson, Peng Liu, ... Yadong Huang in Nature Neuroscience
    Article Open access 13 November 2023
  14. Tau Pathology in Neurodegenerative Diseases

    Aggregation and cellular accumulation of tau protein is a defining feature of tauopathies, a class of histopathologically and clinically...
    Thomas Vogels, Tomáš Hromádka in Neurodegenerative Diseases Biomarkers
    Protocol 2022
  15. Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology

    Background

    Granulovacuolar degeneration bodies (GVBs) are intracellular vesicular structures that commonly accompany pathological tau accumulations in...

    Marta Jorge-Oliva, Jasper F. M. Smits, ... Wiep Scheper in Alzheimer's Research & Therapy
    Article Open access 14 December 2022
  16. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease

    Aggregated insoluble tau is one of two defining features of Alzheimer’s disease. Because clinical symptoms are strongly correlated with tau...

    Kanta Horie, Gemma Salvadó, ... Randall J. Bateman in Nature Medicine
    Article Open access 13 July 2023
  17. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice

    Background

    Alzheimer’s disease (AD) is the leading cause of dementia in the world. The pathology of AD is affiliated with the elevation of both tau...

    Dorit Farfara, Meital Sooliman, ... Dan Frenkel in Journal of Neuroinflammation
    Article Open access 26 July 2023
  18. Cognitive, functional, and neuropsychiatric correlates of regional tau pathology in autopsy-confirmed chronic traumatic encephalopathy

    Background

    Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease characterized by hyperphosphorylated tau (p-tau) accumulation. The...

    Michael L. Alosco, Micaela White, ... Jesse Mez in Molecular Neurodegeneration
    Article Open access 06 February 2024
  19. Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite Pathology

    Proteasomal degradation of intrinsically disordered proteins, such as tau, is a critical component of proteostasis in both aging and...

    Elly E. Liao, Mu Yang, ... Jonathan N. Sachs in Molecular Neurobiology
    Article 10 July 2023
  20. Direct and Indirect Effects of Filamin A on Tau Pathology in Neuronal Cells

    In Alzheimer disease (AD), Tau, an axonal microtubule-associated protein, becomes hyperphosphorylated, detaches from microtubules, accumulates, and...

    Stéphanie Levert, Julie Pilliod, ... Nicole Leclerc in Molecular Neurobiology
    Article Open access 18 November 2022
Did you find what you were looking for? Share feedback.